The grants were awarded to the following College of Medicine researchers:
- Francisco Cayabyab, assistant professor of physiology, was awarded $303,468 over three years to use cutting-edge imaging technology, biochemical and electrophysiological techniques, along with human breast cancer cells, to determine how estrogen triggers potassium ion channel expression and cancer cell growth—work that may ultimately identify new anti-cancer drug targets that inhibit breast tumors.
- Andrew Freywald, associate professor of pathology, was awarded with U of S co-investigators Scot Leary, assistant professor of biochemistry, and Rajni Chibbar, associate professor of pathology, $366,171 over three years, to identify new mechanisms for controlling cancer resistance. This work may lead to new approaches to effectively treat breast cancer by activating a protein that helps to trigger cancer cell death.
- Wei Xiao, professor of microbiology and immunology, was awarded with U of S co-investigator Ron Geyer, professor of pathology, $375,000 to determine how the Uev1 gene plays its role in promoting breast cancer and develop reagents specifically targeting the longer form of the gene for breast cancer diagnosis and treatment.
"Guided by principles of rigour, accountability, fairness and transparency, the Foundation is committed to ensuring grant investments made on behalf of its donors and supporters will positively impact the lives of those most affected by breast cancer," says Shirley Forrest, board chair for the Canadian Breast Cancer Foundation - Prairies/NWT Region.
Support for 14 research projects was announced today by the CBCF in four research categories: basic biomedical, clinical, health services and policy research and psychosocial, cultural and environmental determinants of health over the next three years.
For more information, please contact:
Media Relations Specialist
University Marketing and Communications Team